Europe ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021) August 2017
Europe ICU Sedation Drugs Market Report Scope of the Report The report entitled “Europe ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)�, provides analysis of Europe ICU sedation drugs market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis of the Europe ICU sedation drugs market includes the market by value and by segments. Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall the Europe ICU sedation drugs market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Aspen Pharmacare, Perrigo, Orion Corporation and Primex Pharmaceuticals are some of the key players operating in the Europe ICU sedation drugs market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage Aspen Pharmacare Perrigo Orion Corporation Primex Pharmaceuticals
Europe ICU Sedation Drugs Market Report Executive Summary Sedation is described as the action of reducing apprehension, stress, irritability or excitement by administration of a sedative agent or drug. A sedative is a medication that commonly induces into nervous system to calm and to relax. Significantly, sedation is utilized as a part of minor surgeries like dentistry, some corrective surgeries or to deal with high tension patients. Sedation is accomplished along a continuum of sedation levels: minimal sedation, moderate sedation, deep sedation and general anesthesia. The pathway by which a medicine or liquid is entered into the body is called as route of administration. Sedatives are administered through various medium namely; inhalation, tablets, injections, or Intravenous (IVs). Commonly used route of administration are Intravenous (IVs) and Inhalation. An intravenous route used a venipuncture as a means of injecting central nervous system depressants into the bloodstream. The major intravenous anesthetic drugs are: Remifentanil, Midazolam, Propofol and Dexmedetomidine An inhalational sedation uses inhalable route of administration, through an anesthesia mask, laryngeal mask airway or tracheal tube connected to an anesthetic and an anesthetic delivery system like AnaConDa and Mirus. The major inhalational sedation or anesthetic agents that uses inhalable route of administration are: Sevoflurane, Isoflurane and Desflurane. The Europe ICU sedation drugs market is expected to increase at high growth rates during the forecasted period (2017-2021). The Europe ICU sedation drugs market is supported by various growth drivers, rising geriatric population, adoption of sedentary lifestyle, increasing number of surgeries, increasing healthcare expenditure, etc. Some challenges that hinder the growth are adverse effects of sedative drugs, lack of trained healthcare providers and environmental issues, etc.
Europe ICU Sedation Drugs Market Overview
US$ Million
EUR Million
Europe ICU Sedation Drugs Market by Value; 2013-2016 (US$ Million)
2013
2014 2015 US$ Million
2016
Europe ICU Sedation Drugs Market by Segment; 2016-2017
US$ Million
EUR Million
Europe ICU Sedation Drugs Market by Value; 2017-2021 (US$ Million)
2017
2018 2019 US$ Million
2020 Euro Million
2021
The value of ICU sedation drugs market in Europe was US$... million in 2016, indicating an increase as compared to US$...million in 2015. The ICU sedation drugs market is anticipated to reach to US$... million in 2021, as compared to US$.... million in 2017. Europe ICU sedation drugs market is estimated to grow at a CAGR of …% over the forecasted period 2017 to 2021. The ICU sedation drugs market in Europe can be fragmented into segments on the basis of drugs used for sedation such as……..
2016 2017
Europe ICU Sedation Drugs Market Segments Overview
2013
2014 US$ Million
2015 2016 Euro million
EUR Million
US$ Million
2014 US$ Million
2015 2016 Euro million
EUR Million 2013
Europe Remifentanil ICU Sedation Drugs Market by Value; 2013-2016 (US$ Million)
2013
Europe Dexmedetomidine ICU Sedation Drugs Market by Value; 2013-2016(US$ Million)
US$ Million
EUR Million
US$ Million
Europe Propofol ICU Sedation Drug Market by Value
2014 US$ Million
2015 2016 Euro million
The dexmedetomidine drug market was US$.. million in 2016, increasing from US$.. million in 2015. The market depicted a growth at a CAGR of ‌% over 2013-2016 years. The Remifentanil drug market value was US$... million in 2016.
Title: European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021) Published: August 2017 Pages: 56 Price: US$ 800 (Single-User License) : US$ 1600 (Corporate License) For more Info: http://www.daedal-research.com// european-icu-sedation-drugs-market-size-trends-forecasts-2017-2021
For more details please contact Mr. Rajeev Kumar: Tel: +91-120-4553017 (9.30 am - 6.30 pm) IST Mobile: +91-8743975789 (24 X7) Enquiries: info@daedal-research.com
Daedal Research
Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries .